Clinical and immune profiling for cancer of unknown primary site

類似資料

• Mutational activation of the epidermal growth factor receptor down‐regulates major histocompatibility complex class I expression via the extracellular signal‐regulated kinase in non–small cell lung cancer
  著者:: Watanabe, Satomi, 等
  出版事項: (2018)
• Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2
  著者:: Takeda, Masayuki, 等
  出版事項: (2018)
• A case of ALK-rearranged non–small cell lung cancer that responded to ceritinib after development of resistance to alectinib
  著者:: Makuuchi, Yosuke, 等
  出版事項: (2018)
• Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial
  著者:: Hayashi, Hidetoshi, 等
  出版事項: (2020)
• KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival
  著者:: Terashima, Masato, 等
  出版事項: (2014)